Innovation in therapeutic strategies. We develop advanced models of disease and use our expertise in genetic and drug screens, cell biology, chemical biology, gene therapy, pathology and medicinal chemistry to discover targets and develop new drugs, with a view towards innovative therapeutic strategies.Theme Lead: Professor Liz Patton Mark Arends Research Group Colorectal Cancer Pathology Kathryn Ball Research Group Proteostasis and Immune Signalling in Cancer and Dementia Peter Bankhead Research Group Bioimage analysis and digital pathology Chris Boyd Research Group Development of pulmonary gene therapy approaches to treat cystic fibrosis and other genetic diseases Val Brunton Research Group Signalling and the regulation of cancer growth and metastasis Neil Carragher Research Group Drug Discovery Farhat Din Research Group Metabolism and Energy Signalling in Colorectal Cancer Margaret Frame Research Group Adhesion networks in cancer Simon Herrington Research Group Molecular Cancer Pathology Ted Hupp Research Group Next Generation Technologies for Drug Discovery In Cancer Kevin Myant Research Group Colorectal Stem Cell Transformation Liz Patton Research Group Discovery and clinical melanoma research to advance therapies and care for human and veterinary melanoma patients. Alan Serrels Research Group Tumour Immune Environment Lesley Stark Research Group NF-kB - Nucleolar Signalling Asier Unciti-Broceta Research Group Innovative Therapeutics Andrew Wood Research Group Genome editing and targeted protein degradation This article was published on 2026-01-05
